AUSTIN, Texas, May 12, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that Dr. Andrew Brenner, development leader of an innovative drug portfolio ...

Brenner is a professor of medicine in the division of hematology and oncology at The University of Texas Health Science Center at San Antonio and scientific advisory board member at Plus Therapeutics.

COLUMBUS, Ohio (WCMH) — A new bill that would get rid of school levies and Ohio’s EdChoice program had its first hearing this week. Sen. Andrew Brenner (R-Delaware) introduced Senate Bill 93, which ...

COLUMBUS, Ohio — Sen. Andrew Brenner wants to create a new system for funding Ohio’s public schools. The Delaware County Republican unveiled Senate Bill 93 Tuesday, which would replace all local ...

Andrew Brenner, MD, PhD, is a breast and neuro-oncology specialist and professor of medicine in the Division of Hematology and Oncology at the University of Texas Health Science Center at San Antonio.